Biotech

All Articles

Analysts dig into Avidity's DMD win, revealing subtleties in records

.Avidity Biosciences amazed financiers with period 1/2 data in Duchenne muscle dystrophy (DMD) Frida...

Actinogen's cortisol blocker falls short stage 2 depression research

.Actinogen Medical's cortisol blocker has skipped the key endpoint of a phase 2 research study in an...

Bivictrix decides going personal only way to take ADC in to medical clinic

.Antibody-drug conjugates (ADCs) have actually gone to the facility of several a billion-dollar biob...

TPG tops up funds to $580M for assets around life sciences

.Property supervisor TPG, which has supported biotechs including Sionna Rehabs and also Santa Clam A...

Merck ceases phase 3 TIGIT trial in bronchi cancer for futility

.Merck &amp Co.'s TIGIT plan has actually gone through an additional drawback. Months after shutteri...

After a tough year, Exscientia folds right into Recursion

.After a year determined by pipeline cuts, the shift of its own chief executive officer and also lay...

Cullinan, after $25M offer, restore bispecific to Port

.Cullinan Rehab was excited good enough along with Port BioMed's bispecific invulnerable activator t...

A nearer examine Tough Biotech's Tough 15

.In this particular week's incident of "The Best Line," our experts are actually diving in to Fierce...

Lilly faces period 2 failing of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's event commemorating the approval of ...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of significant management hirings, shootings...